Outcome of patients with low‐risk and intermediate‐1‐risk myelodysplastic syndrome after hypomethylating agent failure: A report on behalf of the MDS Clinical Research Consortium

Overview of attention for article published in Cancer (0008543X), November 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

news: 1 news outlet
twitter: 6 X users
facebook: 3 Facebook pages

googleplus: 1 Google+ user
guideline: 1 clinical guideline source

Readers on

mendeley: 50 Mendeley

So far, Altmetric has seen 7 X posts from 6 X users, with an upper bound of 62,951 followers.

This paper defines natural history of patients with lower risk MDS and hypomethylating failure. This is new... http://t.co/FkoVZr2NaO

Outcome of patients with low-risk and intermediate-1-risk MDS after hypomethylating agent failure. http://t.co/Lvx0ZdPnZC

Very important paper describing the natural outcome of patients with lower risk MDS and hypomethylating failure... http://t.co/smdmtXXRp4

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 3 additional X posts.